SEC 13F Intelligence

Weaver C. Barksdale & Associates, Inc. / DGX

Weaver C. Barksdale & Associates, Inc.’s Quest Diagnostics Inc Position

Does Weaver C. Barksdale & Associates, Inc. own Quest Diagnostics Inc (DGX)? Not currently — the last reported position was 14.5K shares worth $2M in Q4 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q4 2022
Shares
14.5K
% of Portfolio
+2.00%
Quarters Held
5
position exited

Position History DGX

Reported value by quarter
Q4 ’21: $2MQ4 ’21Q1 ’22: $2MQ1 ’22Q2 ’22: $2MQ2 ’22Q3 ’22: $2MQ3 ’22Q4 ’22: $2MQ4 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202214.5K$2M+2.00%
Q3 202214.1K$2M+1.74%
Q2 202214.7K$2M+1.81%
Q1 202213.8K$2M+1.68%
Q4 202113.6K$2M+2.13%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Weaver C. Barksdale & Associates, Inc.’s full portfolio or all institutional holders of DGX.